Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
China Isotope & Radiation Corp. ( (HK:1763) ) has shared an announcement.
China Isotope & Radiation Corporation announced the successful launch of the first batch of carbon-14 isotope products by its subsidiary, CNNC Qinshan Isotope Co., Ltd. This marks a significant milestone in China’s capability to independently produce and supply carbon-14 isotopes for commercial use, utilizing advanced technology with high efficiency and low waste. The development is expected to enhance the company’s market position and contribute to the high-quality development of the nuclear technology industry in China.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation (CIRC) operates in the nuclear technology industry, focusing on the production and supply of isotopes and related products. It is involved in the independent research, development, and market-oriented supply of isotopes, with a particular emphasis on advancing nuclear technology applications in alignment with national strategies.
Average Trading Volume: 274,675
Technical Sentiment Signal: Hold
Current Market Cap: HK$3.68B
For an in-depth examination of 1763 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue